Browse 6,000+ US-traded stocks with real-time quotes, AI-powered analysis, options flow intelligence, earnings predictions, and multi-signal convergence detection. Filter by sector, market cap, price range, and signal strength to find stocks matching your investment criteria.
What You Get
Real-time stock quotes from a 5-source consensus pricing engine
AI analysis with buy/sell/hold signals backed by 12 independent indicators
Options flow tracking — unusual activity, put/call ratios, and open interest anomalies
Earnings predictions with historical beat rates and EPS estimates
Convergence scanner detecting when multiple signals align on a single stock
Sector and industry filtering across all 11 GICS sectors
Frequently Asked Questions
Is the stock screener free?
Yes, iGotFomo provides completely free access to real-time stock data, AI analysis, and all screening tools with no account required.
How many stocks are covered?
Over 6,000 US-traded stocks including all NYSE, NASDAQ, and AMEX listings. Data is updated in real-time during market hours.
BTAI Stock Price Today $1.61 (-2.42%) ▼
About BioXcel Therapeutics, Inc. (BTAI)
BioXcel Therapeutics, Inc. (BTAI) is a publicly traded company in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry. View real-time stock data, AI analysis, options flow, and convergence signals for BTAI on iGotFomo.
BioXcel Therapeutics, Inc. (BTAI) is a publicly traded company in the Healthcare sector, operating in the Drug Manufacturers - Specialty & Generic industry.
What is the current BTAI stock price?
As of the latest trading session, BTAI trades at $1.61 per share, with a daily change of -2.42%.
What is BTAI's market capitalization?
BioXcel Therapeutics, Inc. has a market capitalization of $35 million, making it a micro-cap stock.
What sector does BTAI belong to?
BioXcel Therapeutics, Inc. operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry. View all Healthcare stocks.